# Rehab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rehab

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: https://rehabforjapan.com
- Total disclosed funding: $24M
- Latest round: Series D (Feb 16, 2024)
- Investors on record: 16

## About

Based in Tokyo, Japan, and founded in 2016, Rehab for JAPAN Inc., d.b.a. Rehab, provides rehabilitation and care management software as a service, online rehabilitation services, and nursing care data analytics platforms for care providers. In May 2026, Rehab raised an undisclosed amount in venture funding from Ono Digital health Investment, GK. As of  May 2026, Ryo Okubo is the CEO of the company.

The company offers several services, including Rehabilitation SaaS, which provides scientific nursing care software for facilities, and an online rehabilitation business for support services not covered by insurance. The firm also operates a nursing care data business, creating a data platform for analyzing and co-creating nursing care solutions.

The company plans to use its proceeds from April 2026 to expand the deployment of its long-term care technology and data platform and develop new services.

## Funding rounds

- Series D, Feb 16, 2024, $6.7M — SMBC Venture Capital, Monex Ventures, Japan Post Investment Corporation, Ono Digital health Investment, GK.
- Series D, Feb 1, 2023, $8.7M — SMBC Venture Capital, Omron Ventures, Japan Post Investment Corporation, Capital Medica Ventures, MTG Ventures, Nanto Capital Partners, Aflac Ventures Japan, Ono Digital health Investment, GK.
- Series C, May 24, 2021, $6.4M — Mitsubishi UFJ Capital, SMBC Venture Capital, Global Brain, Cyberdyne, Inc., Capital Medica Ventures, Toyoshima, CEJ Capital, MTG Ventures, Ono Pharmaceutical
- Series B, Feb 3, 2020, $1.5M — SMBC Venture Capital, Monex Ventures, Capital Medica Ventures
- Series A, Aug 10, 2018, $0.9M — Capital Medica Ventures, Lifetime Ventures

## Investors

- Capital Medica Ventures (https://capitalatlas.ai/funds/capital-medica-ventures) — Series A, Series B, Series C, Series D
- Lifetime Ventures (https://capitalatlas.ai/funds/lifetime-ventures) — Series A
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series B, Series C, Series D
- Monex Ventures (https://capitalatlas.ai/funds/monex-ventures) — Series B, Series D
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series C
- Global Brain (https://capitalatlas.ai/funds/global-brain) — Series C
- Cyberdyne, Inc. — Series C
- Toyoshima — Series C
- CEJ Capital (https://capitalatlas.ai/funds/cej-capital) — Series C
- MTG Ventures (https://capitalatlas.ai/funds/mtg-ventures) — Series C, Series D
- Ono Pharmaceutical — Series C
- Omron Ventures (https://capitalatlas.ai/funds/omron-ventures) — Series D
- Japan Post Investment Corporation — Series D
- Nanto Capital Partners (https://capitalatlas.ai/funds/nanto-capital-partners) — Series D
- Aflac Ventures Japan — Series D
- Ono Digital health Investment, GK. — Series D